Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
1.
J Orthop Trauma ; 26(4): 200-5, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22011637

ABSTRACT

OBJECTIVES: The aim of our study was to develop a minimally invasive endoscopic procedure (osteoscopy), which is capable of visualizing blood supply and quantitatively assessing circulation to the femoral head at the time of definitive surgery. METHODS: The new diagnostic technique was developed in animal experiments (four piglets) and was subsequently tested in nine consecutive patients requiring surgery for a femoral neck fracture. The direct visualization of the femoral head circulation was performed in the mortise prepared for the implant. The osteoscope optic fiber was placed at the orifice of the cavity created by the custom-made drill bit. The "mortise-sleeve-optic" system was connected to a manometer and a saline reservoir. The bleeding from the wall of bony cavity was observed, meanwhile the inner pressure of the "mortise-sleeve-optic" system was changed gradually. The pressure measurement at the first appearance of bleeding and the intraosseal pressure was recorded. RESULTS: The animal investigations demonstrated that the osteoscopy readily distinguished among diffuse bleeding, pulsatile bleeding, and the absence of bleeding in the femoral head. The human experiments proved that a different quality of the femoral head circulation can be observed during osteoscopy. CONCLUSIONS: Preliminary findings indicate that clinical osteoscopy may be a useful tool in the assessment of blood circulation to the femoral head.


Subject(s)
Endoscopy/methods , Femoral Neck Fractures/physiopathology , Femur Head/physiopathology , Rheology/methods , Aged , Aged, 80 and over , Animals , Blood Flow Velocity , Female , Femur Head/blood supply , Humans , Male , Middle Aged , Pilot Projects , Rheology/instrumentation , Sensitivity and Specificity , Swine
2.
J Oral Maxillofac Surg ; 69(4): 1242-7, 2011 Apr.
Article in English | MEDLINE | ID: mdl-20685021

ABSTRACT

PURPOSE: A novel use of site-limited platysma-based transpositional flap is demonstrated and discussed for the reconstruction of facial defects. MATERIALS AND METHODS: Between January 1985 and January 2001, 342 patients were operated on for advanced oral-oropharyngeal and orofacial cancers. In 6 cases, a platysma-based transpositional flap was used for external closure of facial through-and-through defects. Internally, the saved oral mucosa was used in 4 patients and fasciocutaneous forearm free flaps in 2 patients. The facial artery was blocked in all cases. RESULTS: The postoperative course was uneventful except in 1 case, when partial loss of the flap was observed intraorally. The externally used transpositional platysma-based flap showed cosmetic and functional advantages: its consistency, color, and texture were similar to those of the original facial tissues, the area of operation was the same, and the donor site was closed primarily. CONCLUSION: The site-limited platysma-based myocutaneous transpositional flap is usable and safe even in those cases in which circulation of the facial artery is damaged or local vascular compromise has occurred and the facial through-and-through defect is extended. The facial reconstruction described is one of several applicable reconstructive methods that may be chosen for special facial defects. The method is not applicable when the neck is radically operated on (radical neck dissection) and/or irradiated. No similar use of platysma-based transpositional flaps has been reported thus far.


Subject(s)
Face/surgery , Neck Muscles/transplantation , Plastic Surgery Procedures/methods , Skin Transplantation/methods , Surgical Flaps , Adult , Arteries/pathology , Face/blood supply , Facial Neoplasms/surgery , Fascia/transplantation , Female , Follow-Up Studies , Forearm/surgery , Free Tissue Flaps , Graft Survival , Humans , Male , Middle Aged , Mouth Mucosa/transplantation , Mouth Neoplasms/surgery , Muscle, Skeletal/transplantation , Neoplasm Recurrence, Local/pathology , Oropharyngeal Neoplasms/surgery , Radiotherapy, Adjuvant , Surgical Flaps/blood supply , Tissue and Organ Harvesting/methods , Wound Healing/physiology
3.
Pathol Oncol Res ; 16(2): 207-12, 2010 Jun.
Article in English | MEDLINE | ID: mdl-19757193

ABSTRACT

The purpose of this clinicopathological study was to evaluate the effects and efficiency of combined neoadjuvant chemotherapy related to surgical margin. 100 consecutively treated squamous cell cancer patients receiving a combined neoadjuvant therapy were selected (Bleomycin-Vincristin-Methotrexate (BVM) or BVM + Mitolactol or BVM + Cisplatin). After three courses of chemotherapy, the patients were operated on. The largest diameter of the primary tumors was compared before and after chemotherapy. In the surgical specimen, the involvement of surgical margin was assessed. The largest diameter before chemotherapy was: T2 30%; T3 55%; T4A 15%. After chemotherapy, the rest tumor was assessed in the surgical specimen as: no rest 11%; <2 cm 57%; 2-4 cm 28%; 4-6 cm 4%. The no rest and <2 cm (optimal operability) tumor was observed in T2: 94%; in T3: 73%; in the T4A: 0%. Severe side effects (Grade III-IV) were not observed. There was a significant decrease in size (P < 0.0001). Of the 100 surgical specimens, 83% had clear-, 9% close- and 8% involved margins. From T4A, there was a 40% (6 patients) involved margin. Based on the significantly better size and operability of primary T2-3, the mild side effects and the high (83%) percentage of clear surgical margins, that is better than other (without preoperative chemotherapy) results, sought the use of chemotherapy is recommended before surgery. Due to the 40% involved margin, we don't suggest surgery in T4A.


Subject(s)
Carcinoma, Squamous Cell/drug therapy , Carcinoma, Squamous Cell/surgery , Mouth Neoplasms/drug therapy , Mouth Neoplasms/surgery , Antineoplastic Agents/therapeutic use , Antineoplastic Combined Chemotherapy Protocols , Bleomycin , Cisplatin/administration & dosage , Female , Humans , Male , Methotrexate , Middle Aged , Mitolactol , Neoadjuvant Therapy , Neoplasm Staging , Oral Surgical Procedures , Physicians , Surgery, Oral , Vincristine
4.
Rheumatol Int ; 29(7): 793-6, 2009 May.
Article in English | MEDLINE | ID: mdl-19034456

ABSTRACT

The C1858T allele of the PTPN22 gene has been reported to confer risk for RA; but in some reports, the effect was restricted to RF- and/or anti-CCP-seropositive patients. Hungarian RA patients and matched controls were genotyped. The 1858T allele showed an increased prevalence in RA patients compared to controls. The 1858T allele represents a risk factor in the whole RA population (P = 0.001); an association was found both in RF-seropositive (P = 0.001) and anti-CCP-seropositive patients (P = 0.001), and in subjects with the combination of these factors (P = 0.002). In TT homozygotes, the estimated susceptibility to RA was more than double (OR = 5.04) of that seen in TC heterozygotes (OR = 1.89); the same gene dosage effect was observed in all seropositive RA subgroups. Our data show that the Hungarian RA patients belong to the populations in which the 1858T allele represents a susceptibility factor both in the RF- and/or anti-CCP-seropositive subjects, and the association exhibit a gene dosage dependency.


Subject(s)
Arthritis, Rheumatoid/enzymology , Arthritis, Rheumatoid/genetics , Genetic Predisposition to Disease/genetics , Polymorphism, Genetic/genetics , Protein Tyrosine Phosphatase, Non-Receptor Type 22/genetics , Adult , Age Distribution , Aged , Arthritis, Rheumatoid/ethnology , DNA Mutational Analysis , Female , Gene Dosage/genetics , Gene Frequency/genetics , Genetic Markers/genetics , Genetic Testing , Genotype , Homozygote , Humans , Hungary/ethnology , Lymphocyte Activation/genetics , Male , Middle Aged , Rheumatoid Factor/genetics , Sex Distribution , T-Lymphocytes/enzymology
6.
Autoimmun Rev ; 7(6): 463-7, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18558363

ABSTRACT

Because of their endosymbiotic evolutionary origin, proteins compartmentalized into mitochondria represent an interesting transition from prokaryotic foreign to essential self molecules. We investigated the presence of naturally occurring antibodies (nAbs) recognizing mitochondrial inner membrane enzymes. Epitope mapping analysis of a mitochondrial inner membrane enzyme, citrate synthase (CS) by synthetic overlapping peptides and phage display libraries using sera from healthy individuals and from patients having systemic autoimmune disease revealed CS recognizing nAbs with IgM isotype. We analyzed cross-reactive epitopes on human CS, bacterial CS, and various standard autoantigens. We have found that the fine epitope pattern on CS is different under physiological and pathological conditions. Moreover sera affinity purified on CS cross reacts with nucleosome antigen, which cross-reactivity could be mapped to a short epitope on human CS. These data indicate that in theory, nAbs "specific" for a given self antigen could fulfill the function of participating in innate defense mechanisms and at the same time recognize a target antigen in a systemic autoimmune disease. Thus, at the level of recognized epitopes there is a possible link between the innate like part and the adaptive-autoimmune arm of the humoral immune system.


Subject(s)
Autoantibodies/immunology , Citrate (si)-Synthase/immunology , Mitochondrial Proteins/immunology , Autoantibodies/biosynthesis , Autoantibodies/blood , Bacteria/enzymology , Bacterial Proteins/chemistry , Bacterial Proteins/immunology , Citrate (si)-Synthase/chemistry , Cross Reactions , Epitope Mapping , Heart Transplantation , Humans , Immunoglobulin Isotypes/blood , Mitochondria/enzymology , Mitochondrial Proteins/chemistry
7.
Fogorv Sz ; 101(6): 219-23, 2008 Dec.
Article in Hungarian | MEDLINE | ID: mdl-19260622

ABSTRACT

Sialolithiasis is a common disease of the salivary glands and a major cause of salivary gland dysfunction. The dominance of submandibular sialoliths is widely investigated. Giant stones (>15 mm) are rare, approximately every tenth or twelfth of the stones belong to this category. Sialo-oral or sialo-cutaneous fistula formation promotes the growth of an excessive size. In their presentation, the authors would like to introduce the diagnostic and therapeutic process of a giant (27 mm) submandibular sialolith and give a review of the literature.


Subject(s)
Oral Surgical Procedures , Salivary Gland Calculi/diagnosis , Salivary Gland Calculi/surgery , Submandibular Gland/pathology , Cutaneous Fistula/diagnosis , Cutaneous Fistula/etiology , Cutaneous Fistula/surgery , Humans , Male , Middle Aged , Oral Surgical Procedures/methods , Salivary Gland Calculi/complications , Salivary Gland Calculi/pathology , Salivary Gland Fistula/diagnosis , Salivary Gland Fistula/etiology , Salivary Gland Fistula/surgery , Submandibular Gland/surgery
8.
J Craniomaxillofac Surg ; 34(6): 362-5, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16860564

ABSTRACT

INTRODUCTION: Achieving the necessary occlusion for orthognathic surgery is not possible with conventional oral intubation since the tube interferes with the occluding teeth. Sometimes nasotracheal intubation is impossible due to developmental malformations requiring repair. Also, the oral or nasotracheal tube may interfere with the operation or may be damaged during the procedure. In 1986, Hernandez Altemir described a method of submental endotracheal intubation. His intentions were to avoid tracheostomy in maxillofacial trauma cases where short-term intermaxillary fixation was required. PATIENTS: Between January 2000 and May 2003, 13 patients were operated on, using submental intubation. Eight of these (three females and five males) had surgery for orthognathic malformations. METHODS: The Hernandez Altemir technique was modified to ease the procedure: a sterile nylon guiding tube and the '222 rule' incision were introduced. Eight cases with concurrent complex orthognathic surgery, using this modified technique are reported in this paper. RESULTS: There were no operative or postoperative complications related to the procedure. CONCLUSION: The technique is easy to use, rapid and free of complications compared to 'alternative' intubation methods (tracheostomy, retromolar location of tube, etc.). Submental scarring is acceptable. It is recommended for orthognathic procedures in selected cases.


Subject(s)
Intubation, Intratracheal/methods , Maxilla/surgery , Osteotomy, Le Fort/methods , Adolescent , Adult , Female , Humans , Male , Mouth Floor/surgery
9.
Anticancer Res ; 26(2B): 1557-62, 2006.
Article in English | MEDLINE | ID: mdl-16619571

ABSTRACT

BACKGROUND: This prospective randomized study was undertaken to assess the effectiveness of oral pilocarpine chloratum (Salagen) during and after radiotherapy. PATIENTS AND METHODS: Between October 1999 and December 2003, 66 patients received 60 Gy of irradiation to their head and neck cancer. Half of the patients received 5 mg oral pilocarpine 3 times a day from the beginning of radiotherapy over a period of 12 weeks. The control group received similar doses of pilocarpine only in the second 6 weeks following irradiation. Patient saliva secretion was recorded, and a visual analog scale measuring overall and daily xerostomia, difficulty in sleeping, speaking, eating and wearing dentures was employed. RESULTS: Pilocarpine, given concomitantly with radiotherapy, statistically improved the salivary flow and induced better patient comfort by the end of radiotherapy. Patient comfort and symptoms related to xerostomia greatly decreased compared to patients receiving pilocarpine after irradiation in the second 6-week period of therapy. The patients' quality of life, saliva production and symptoms related to xerostomia showed significant progress by the end of the 12 weeks. CONCLUSION: The results suggest that stimulated salivary glands suffer less decrease in saliva production during radiotherapy. The stimulated saliva flow reduced the side-effects of irradiation.


Subject(s)
Head and Neck Neoplasms/drug therapy , Head and Neck Neoplasms/radiotherapy , Muscarinic Agonists/therapeutic use , Pilocarpine/therapeutic use , Radiation Injuries/drug therapy , Xerostomia/drug therapy , Administration, Oral , Female , Humans , Male , Middle Aged , Muscarinic Agonists/adverse effects , Pilocarpine/adverse effects , Prospective Studies , Quality of Life , Radiation Injuries/etiology , Radiation Injuries/prevention & control , Radiotherapy/adverse effects , Salivation/drug effects , Salivation/radiation effects , Xerostomia/etiology , Xerostomia/prevention & control
10.
Pathol Oncol Res ; 12(1): 34-40, 2006.
Article in English | MEDLINE | ID: mdl-16554914

ABSTRACT

Although the pathogenetic significance of hepatitis B virus x protein (HBxAg) in chronic hepatitis, liver cirrhosis, and primary hepatocellular carcinoma has already been studied, the comparative analyses of both the actual serum HBxAg levels and antibody production against various HBx epitopes have been examined to lesser extent. We have simultaneously investigated the relationship between antibody production (IgG and IgM) against the HBxAg fragments and HBxAg level in the sera of patients with acute (14) or chronic hepatitis (80) and symptomless carriers (12). A recently developed sandwich-type ELISA was used for the quantitative measurements of HBxAg. Overlapping recombinant and synthetic antigens were used to map the fine epitope specificities of circulating anti-HBx antibodies. In acute hepatitis, we have found high and homogenous correlation in the IgM type immune responses against all the examined HBxAg regions. Moreover, strong correlation has been observed between IgG type immune responses to a characteristic C-terminal region (C1: 79-117) and the longest fragment (X: 10-143). Moderate correlation has been found between HBxAg concentration and the IgG type anti-HBx antibody levels against C-terminus of HBxAg in patients with chronic hepatitis. In the case of symptomless carriers, there were also demonstrable associations in the immune responses against the C-terminal sequences; however, significant correlations were found for antibody production against the N-terminal region as well. The examinations show that the C-terminal sequence, responsible for transactivation, promotes an efficient IgG antibody response in all three groups of patients, whereas the negative regulator N-terminal part of the HBxAg molecule for the most part does not trigger antibody production. This suggests that the immune responses against various - biologically active - epitopes of the HBxAg may have a different role in the pathogenesis of hepatitis and may be used as prognostic markers in human HBV infections.


Subject(s)
Hepatitis B Antibodies/blood , Hepatitis B/blood , Hepatitis B/immunology , Trans-Activators/blood , Amino Acid Sequence , Antibody Specificity , Enzyme-Linked Immunosorbent Assay , Humans , Molecular Sequence Data , Prognosis , Recombinant Proteins/immunology , Regression Analysis , Sequence Homology, Amino Acid , Trans-Activators/genetics , Trans-Activators/immunology , Viral Regulatory and Accessory Proteins
11.
Mol Immunol ; 43(11): 1761-8, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16368144

ABSTRACT

Natural antibody (nAb) producing B-1 B cells are considered an intermediate stage of evolution between innate and adaptive immunity. nAbs are immunoglobulins that are produced without antigen priming. nAbs can recognize foreign targets and may serve in the first line of immune defense during an infection. Natural autoantibodies (nAAbs) present in the serum of both healthy humans and patients suffering from systemic autoimmune diseases recognize a set of evolutionarily conserved self-structures. Because of their endosymbiotic evolutionary origin, proteins compartmentalized into mitochondria represent an interesting transition from prokaryotic foreign (non-self) to essential (self) molecules. We investigated the possible overlap in recognized epitopes of innate and self-reactive nAbs and surveyed changes in physiological autoreactivity under pathological autoimmune conditions. Epitope mapping analysis of a mitochondrial inner membrane enzyme, citrate synthase (CS) (EC 2.3.3.1) by synthetic overlapping peptides and phage display libraries using sera from healthy individuals and from patients having systemic autoimmune disease revealed CS recognizing nAAbs with IgM isotype. We analyzed cross reactive epitopes on human CS, bacterial CS, and various standard autoantigens. The anti-CS nAAbs by participating in the nAb network, could function in innate defense mechanisms and at the same time recognize a target antigen (nucleosome) in a systemic autoimmune disease. Thus, at the level of recognized epitopes there is a possible new link between the innate like component and the adaptive-autoimmune arm of the humoral immune system.


Subject(s)
Autoantibodies/immunology , Citrate (si)-Synthase/immunology , Citrate (si)-Synthase/metabolism , Immunity, Active/immunology , Immunity, Innate/immunology , Mitochondria/enzymology , Mitochondria/immunology , Adult , Amino Acid Sequence , Autoimmune Diseases/immunology , Autoimmunity/immunology , Case-Control Studies , Child , Chromatography, Affinity , Citrate (si)-Synthase/chemistry , Cross Reactions , Female , Humans , Immune Sera/immunology , Male , Molecular Sequence Data , Peptide Library
12.
Fogorv Sz ; 98(5): 193-8, 2005 Oct.
Article in Hungarian | MEDLINE | ID: mdl-16315855

ABSTRACT

The biological age of a child, in contrast to his or her chronological age, may be described in terms of skeletal or dental maturity, the development of secondary sex characters etc. These factors can be applied separately or together to assess the degree of physiological maturity of a growing child. The determination of this physiological age and its correlation to the chronological age is of importance within many fields, such as archaeology, forensic medicine, endocrinology, orthodontics etc. Dental maturity was studied on 203 panoramic radiographs, taken between 1985 and 1995, of healthy Hungarian children aged 2.9 to 17.5 years from the south-west Transdanubian part of Hungary. The revised method of Demirjian was used for determination of the maturity score of each individual. For each tooth a score (on a scale A-H) was given according to the radiographic development, from first appearance of calcification to the closure of the apex. This score was then transformed into a self-weighted maturity score for the dental stages (0-19.3) as presented in the paper. The individual scores were then added giving a total maturity score (0-100). This total maturity score represents the biological maturity of the child and may then be compared with the known chronological age. The total maturity scores of the Hungarian population was plotted against the chronological (real) age, and a curve was fitted using the Lowess method of locally weighted least-square method. Our results show that each population needs its own standards. Hungarian boys and girls are approximately 1 year ahead of their French-Canadian counterparts at the age of 6-8. At older ages, the difference decreases. Similar to other studies, we found high individual variance up to 2 years, in tooth development, in the Hungarian population.


Subject(s)
Aging/physiology , Child Development/physiology , Dentition , Tooth , Adolescent , Child , Child, Preschool , Dentition, Mixed , Dentition, Permanent , Female , Humans , Hungary , Least-Squares Analysis , Male , Radiography, Dental , Sex Characteristics , Sex Distribution , Tooth/diagnostic imaging , Tooth, Deciduous
13.
J Immunol Methods ; 306(1-2): 183-92, 2005 Nov 30.
Article in English | MEDLINE | ID: mdl-16194545

ABSTRACT

The hepatitis B virus X protein (HBxAg) is responsible for severe complications of HBV infections including primary hepatocellular carcinoma. A sandwich type ELISA and a flow cytometric microbead assay for quantitative determination of serum levels of Hbx-Ag are introduced. We have previously developed monoclonal antibody families against well-conserved epitopes on HbxAg, characterized by different immunohistochemical and immunoserological techniques. Special selection of the antibody pairs provided highly sensitive and highly specific tools for quantitative immunoassay development. The resulting assays were tested on human sera (208 samples) collected from patients suffering from different clinical forms of HBV infection. The sensitivity range of the sandwich type ELISA was between 4 and 2000 ng/ml as measured on both the recombinant antigen and the sera of chronic hepatitis patients. A further flow cytometric microbead assay was established and tested in parallel with the ELISA. The quantitative results of these two immunoserological techniques were in strong correlation and they were found to be highly specific and sensitive on clinical samples. The HBxAg ELISA technique is applicable for routine clinical laboratory measurements, and our HBxAg microbead technique is recommended for complex multiparametric measurements combined with other markers.


Subject(s)
Enzyme-Linked Immunosorbent Assay/methods , Flow Cytometry/methods , Hepatitis B/diagnosis , Trans-Activators/blood , Amino Acid Sequence , Antibodies, Monoclonal/immunology , Antibodies, Viral/immunology , Humans , Microspheres , Molecular Sequence Data , Sensitivity and Specificity , Viral Regulatory and Accessory Proteins
14.
Fogorv Sz ; 98(3): 119-23, 2005 Jun.
Article in Hungarian | MEDLINE | ID: mdl-16108416

ABSTRACT

The aim of the authors' study was to compare the remaining root canal wall thickness and the preparation time of root canals, prepared either with step-back technique, or with GT Rotary File, an engine driven nickel-titanium rotary instrument system. Twenty extracted molars were decoronated. Teeth were divided in two groups. In Group 1 root canals were prepared with step-back technique. In Group 2 GT Rotary File System was utilized. Preoperative vestibulo-oral X-ray pictures were taken from all teeth with radiovisiograph (RVG). The final preparations at the mesiobuccal canals (MB) were performed with size #30 and palatinal/distal canals with size #40 instruments. Postoperative RVG pictures were taken ensuring the preoperative positioning. The working time was measured in seconds during each preparation. The authors also assessed the remaining root canal wall thickness at 3, 6 and 9 mm from the radiological apex, comparing the width of the canal walls of the vestibulo-oral projections on pre- and postoperative RVG pictures both mesially and buccally. The ratios of the residual and preoperative root canal wall thickness were calculated and compared. The largest difference was found at the MB canals of the coronal and middle third level of the root, measured on the distal canal wall. The ratio of the remaining dentin wall thickness at the coronal and the middle level in the case of step-back preparation was 0.605 and 0.754, and 0.824 and 0.895 in the cases of GT files respectively. The preparation time needed for GT Rotary File System was altogether 68.7% (MB) and 52.5% (D/P canals) of corresponding step-back preparation times. The use of GT Rotary File with comparison of standard step-back method resulted in a shortened preparation time and excessive damage of the coronal part of the root canal could be avoided.


Subject(s)
Dental Alloys , Dental High-Speed Equipment , Dental High-Speed Technique , Nickel , Root Canal Preparation/instrumentation , Root Canal Preparation/methods , Titanium , Dental Pulp Cavity , Humans , In Vitro Techniques , Molar
15.
Transpl Int ; 17(12): 834-40, 2005 May.
Article in English | MEDLINE | ID: mdl-15711981

ABSTRACT

Autoimmune mechanisms play an important role in the pathogenesis of allograft vasculopathy following heart transplantation, but the autoantigens involved have been only sparsely studied. Citrate synthase (CS) enzyme is a conserved molecule, and, as an important mitochondrial autoantigen, it is protected by the "immunological homunculus". Tissue destruction and alteration of the immune regulatory mechanisms can induce pathological immune response against CS in other autoimmune diseases. In our present study we aimed to detect CS-specific autoantibodies in heart transplant patients, therefore, prospective, randomised clinical tests were conducted on 33 heart transplant patients and compared with 130 healthy blood donors. The level and isotype of CS antibodies were detected by simple binding indirect enzyme-linked immunosorbent assay (ELISA). The epitope specificities of the autoantibodies were measured on synthetic overlapping peptide sequences of CS enzyme by an indirect multi-pin ELISA method. Mainly IgM isotype CS autoantibodies were found in healthy controls, while IgG was found at higher levels and frequency (four-times higher) in heart transplant patients. Autoantibodies of IgG isotype recognise different epitopes than do autoantibodies of IgM isotype, even within the same group and individual. New epitope-specific IgG and IgM isotype autoantibodies appeared in heart transplant patients when compared with the controls. Our findings suggest a possible role of CS-specific autoantibodies in the pathomechanism of allograft vasculopathy.


Subject(s)
Autoantibodies/immunology , Citrate (si)-Synthase/immunology , Epitope Mapping , Heart Transplantation/immunology , Antibody Specificity , Autoantibodies/blood , Citrate (si)-Synthase/chemistry , Humans , Immunoglobulin G/blood , Immunoglobulin G/immunology , Immunoglobulin M/blood , Immunoglobulin M/immunology , Mitochondria/immunology , Protein Structure, Tertiary , Transplantation, Homologous
16.
Anticancer Res ; 24(4): 2557-61, 2004.
Article in English | MEDLINE | ID: mdl-15330214

ABSTRACT

BACKGROUND: This prospective semi-randomized study was undertaken to assess the effects and effectiveness of alkylating drugs in a preoperative setting. PATIENTS AND METHODS: During a 6-year period preceding February 2000, 80 patients with Stage II-IVa (AJCC 2002) squamous cell cancer of the oral cavity were treated. Thirty patients (Group N) received a combination of bleomycin, vincristine and methotrexate (BVM). In the alkylating group, thirty patients (Group A/M) received BVM and mitolactol (dibromodulcitol), while twenty patients (Group A/C) received BVM and cisplatin. Patients underwent surgery within 3 weeks after chemotherapy. Clinical response rate and tumour-free survival were investigated. RESULTS: Clinical complete response was 30%-36% (Group N-A). Partial response was 57%-56% (Group N-A). Side-effects were moderate and reversible. Nausea, anaemia and leucopenia were observed in the alkylating (A) group, while other side-effects (alopecia, mucositis, gastritis) were similar in both groups. The observation time was 36 months. Regional disease-free survival showed a significant difference, favouring the non-alkylating (N) group (p=0.03). A higher metastasis rate was observed in the alkylating (A) group. CONCLUSION: Cisplatin and mitolactol in combination with BVM showed higher local control and lower disease-free survival than BVM alone. That was mostly due to a higher rate of regional metastatis formation in the alkylating-treated patients. This may be a late side-effect caused by the immunosuppressive and myelosuppressive effect of alkylating agents.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoma, Squamous Cell/drug therapy , Oropharyngeal Neoplasms/drug therapy , Antineoplastic Agents, Alkylating/administration & dosage , Antineoplastic Agents, Alkylating/adverse effects , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Bleomycin/administration & dosage , Bleomycin/adverse effects , Cisplatin/administration & dosage , Cisplatin/adverse effects , Disease-Free Survival , Female , Humans , Male , Methotrexate/administration & dosage , Methotrexate/adverse effects , Middle Aged , Mitolactol/administration & dosage , Mitolactol/adverse effects , Prospective Studies , Treatment Failure , Vincristine/administration & dosage , Vincristine/adverse effects
17.
Cancer Detect Prev ; 28(1): 65-71, 2004.
Article in English | MEDLINE | ID: mdl-15041080

ABSTRACT

This prospective randomised study was undertaken to assess the effects and effectiveness of cisplatin in a pre-operative setting. Thirty-eight patients were treated with stage II-IVa (AJCC) squamous cell cancer of the oral cavity and oropharynx. Nineteen patients received a combination of bleomycin, vincristine, methotrexate (BVM; group I.), 19 received BVM and cisplatin (group II). Patients underwent surgery within 3 weeks after chemotherapy. Biopsy and surgical specimens were compared. A clinical complete response was seen in five patients in group I (26.3%) and in four patients in group II (21.1%). Partial response was noted in 11 patients in group I (57.8%) and in 13 patients in group II (68.4%). There was no statistical difference in clinical response between the two groups. Microscopic response was better in the cisplatin treated group. Median follow up of patients is 52 (36-70) months. Disease free survival showed a significant difference, favouring the no cisplatin group (P = 0.03). There was no significant difference in overall survival (P > 0.6). Cisplatin in combination with BVM showed significantly higher levels of microscopic response, but the lower disease free survival is mostly due to a higher rate of regional neck failure.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoma, Squamous Cell/drug therapy , Carcinoma, Squamous Cell/surgery , Cisplatin/administration & dosage , Head and Neck Neoplasms/surgery , Adult , Aged , Biopsy, Needle , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/pathology , Follow-Up Studies , Head and Neck Neoplasms/drug therapy , Head and Neck Neoplasms/mortality , Head and Neck Neoplasms/pathology , Humans , Immunohistochemistry , Middle Aged , Neoplasm Staging , Probability , Prospective Studies , Reference Values , Remission Induction , Risk Assessment , Survival Analysis , Treatment Outcome
18.
Mol Immunol ; 40(5): 241-6, 2003 Sep.
Article in English | MEDLINE | ID: mdl-12943796

ABSTRACT

The recombinant form of the 17kDa, highly hydrophobic and disulfide-bonded hepatitis B virus X protein (HBX) was used for developing a set of monoclonal antibodies (Mab). Our present goal was to determine the fine epitope specificity of our anti-HBX Mab. Based on computer analysis two sequences (amino acids 22-31 and 100-114) were predicted for possessing high immunogenity while the anti-HBX Mab did not recognized them. Limited proteolysis and mass spectroscopic analysis suggested another possible sequence (amino acids 14-26), which also proved to be negative using an immunoserological test. Subsequently, we performed a screen of a phage displayed random peptide library, by which we could localize the epitope to amino acids 88-93. This finding was confirmed using three overlapping fusion peptides spanning amino acids 77-142. Their testing in ELISA assigned the epitope to amino acids 77-95, which supports the result obtained by screening the phage displayed library. Our results suggest the necessity of a complex application of current molecular biological and immunological techniques in fine structure mapping. This approach will be useful to study the prognostic relevance of different antigenic sites on HBX during the development of chronic hepatitis and primary hepatocellular carcinoma.


Subject(s)
Antibodies, Monoclonal/immunology , Epitopes/immunology , Hepatitis B virus/immunology , Trans-Activators/immunology , Animals , Chromatography, High Pressure Liquid , Enzyme-Linked Immunosorbent Assay/methods , Humans , Mice , Viral Regulatory and Accessory Proteins
19.
In Vivo ; 16(5): 307-10, 2002.
Article in English | MEDLINE | ID: mdl-12494868

ABSTRACT

The aim of the study was to monitor the early effect of cytostatics containing platinum on oncogenes in inbred CBA/Ca mice. In human head-neck tumors after treatment with the Cisplatin supplemented BVM (Bleomycin, Vincristine, Methotrexate) protocol, further surgeries are often necessary due to regional recurrence. Body weight equivalent amounts of human dose of Cisplatin were administered intraperitoneally to 6-8-week-old, inbred, female CBA/Ca mice. Twenty four 48 and 72 hours after the treatment RNA was isolated from the target organs and the quantitative expression of c-myc, Ha-ras and p53 genes was examined by dot-blotting in potential target tissues. Significant overexpression of Ha-ras and p53 genes was measured in the bone marrow. Regarding the expression of Ha-ras gene, a significant increase was also found in the lymph nodes after 48 hours. The p53 expression in the lungs was down-regulated compared to the control group. In the "short-term" in vivo test, 24-hour examination of gene expression and amplification is suitable for detecting the early effects of carcinogenetic exposure. Cisplatin-induced gene expression alterations call attention to its possible role in the development of regional recurrence in patients treated with cisplatin-containing regimens.


Subject(s)
Antineoplastic Agents/pharmacology , Cisplatin/pharmacology , Gene Expression Regulation/drug effects , Genes, myc , Genes, ras , Tumor Suppressor Protein p53/genetics , Animals , Antineoplastic Agents/administration & dosage , Bone Marrow/metabolism , Cisplatin/administration & dosage , Immunoblotting , Injections, Intraperitoneal , Lung/metabolism , Lymph Nodes/metabolism , Mice , Mice, Inbred CBA , Proto-Oncogene Proteins c-myc/genetics , Proto-Oncogene Proteins c-myc/metabolism , Proto-Oncogene Proteins p21(ras)/genetics , Proto-Oncogene Proteins p21(ras)/metabolism , RNA, Messenger/genetics , Tumor Suppressor Protein p53/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...